Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 80 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 7968545

    Compositions useful as inhibitors of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  2. US 7964624

    Inhibitors of serine proteases

    Vertex Pharmaceuticals Incorporated · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  3. US 7964748

    Process for preparing intermediates of HMG-CoA reductase inhibitors

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 21, 2011 · Expires Jun 16, 2031

    granted

  4. US 7960415

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  5. US 7960384

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  6. US 7960383

    Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors

    Laboratories Almirall, S.A. · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  7. US 7956220

    MAO-B inhibitors useful for treating obesity

    Jenrin Discovery, LLC · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted

  8. US 7951831

    Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

    The Regents of the University of California · Granted May 31, 2011 · Expires May 26, 2031

    granted

  9. US 7951770

    Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process

    Northwestern University · Granted May 31, 2011 · Expires May 26, 2031

    granted

  10. US 7951820

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2011 · Expires May 26, 2031

    granted

  11. US 7951809

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2011 · Expires May 26, 2031

    granted

  12. US 7943659

    MAPK/ERK kinase inhibitors

    Takeda Pharmaceutical Company Limited · Granted May 17, 2011 · Expires May 12, 2031

    granted

  13. US 7943593

    Compositions comprising inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted May 17, 2011 · Expires May 12, 2031

    granted

  14. US 7943626

    Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

    Takeda Pharmaceutical Company Limited · Granted May 17, 2011 · Expires May 12, 2031

    granted

  15. US 7935693

    Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 3, 2011 · Expires Apr 28, 2031

    granted

  16. US 7928129

    Nanomolar β-lactamase inhibitors

    Northwestern University · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  17. US 7919520

    Inhibitors of tace

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  18. US 7919621

    Tricyclic inhibitors of 5-lipoxygenase

    AMIRA PHARMACEUTICALS, INC. · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  19. US 7919513

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  20. US 7919523

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  21. US 7915305

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

  22. US 7910587

    Quinoxalinyl dipeptide hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  23. US 7906650

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

  24. US 7906523

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 15, 2011 · Expires Mar 10, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.